These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24799349)

  • 1. Treatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold?
    Spencer RN; Carr DJ; David AL
    Prenat Diagn; 2014 Jul; 34(7):677-84. PubMed ID: 24799349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes.
    Kroener L; Wang ET; Pisarska MD
    Semin Reprod Med; 2016 Jan; 34(1):27-35. PubMed ID: 26696276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes.
    Brosens I; Puttemans P; Benagiano G
    Am J Obstet Gynecol; 2019 Nov; 221(5):437-456. PubMed ID: 31163132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A guide towards pre-pregnancy management of defective implantation and placentation.
    Urato AC; Norwitz ER
    Best Pract Res Clin Obstet Gynaecol; 2011 Jun; 25(3):367-87. PubMed ID: 21333605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.
    Staff AC; Fjeldstad HE; Fosheim IK; Moe K; Turowski G; Johnsen GM; Alnaes-Katjavivi P; Sugulle M
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S895-S906. PubMed ID: 32971013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
    Yagel S; Cohen SM; Goldman-Wohl D
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
    Pels A; Ganzevoort W; Kenny LC; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Leemhuis AG; Groom KM; Sharp AN; Magee LA; Jakobsen JC; Mol BWJ; Papageorghiou AT
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD014498. PubMed ID: 37428872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia.
    Caniggia I; Winter J; Lye SJ; Post M
    Placenta; 2000; 21 Suppl A():S25-30. PubMed ID: 10831118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
    Ilekis JV; Tsilou E; Fisher S; Abrahams VM; Soares MJ; Cross JC; Zamudio S; Illsley NP; Myatt L; Colvis C; Costantine MM; Haas DM; Sadovsky Y; Weiner C; Rytting E; Bidwell G
    Am J Obstet Gynecol; 2016 Jul; 215(1 Suppl):S1-S46. PubMed ID: 26972897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of placental-derived fetal growth restriction.
    Burton GJ; Jauniaux E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental bed research: II. Functional and immunological investigations of the placental bed.
    Harris LK; Benagiano M; D'Elios MM; Brosens I; Benagiano G
    Am J Obstet Gynecol; 2019 Nov; 221(5):457-469. PubMed ID: 31288009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
    Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective implantation and placentation: laying the blueprint for pregnancy complications.
    Norwitz ER
    Reprod Biomed Online; 2006 Oct; 13(4):591-9. PubMed ID: 17007686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
    Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
    JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.
    Furuya M; Ishida J; Aoki I; Fukamizu A
    Vasc Health Risk Manag; 2008; 4(6):1301-13. PubMed ID: 19337544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.